Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  V.TLT.W | TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by gebremeskelon Feb 22, 2022 6:15pm
504 Views
Post# 34451948

RE:RE:RE:News is taking way too long..............

RE:RE:RE:News is taking way too long..............Longs will remember that Theralase actually did appoint a professional Director of Investor Relations named Michael Borovec back in 2015. That didn't work out too well either (especially for Michael Borovec).

After he left the company he took to attacking Roger and Kristina anonymously (he thought) on this very board. In 2020 he was ordered by an Ontario Superior Court judge to pay Theralase $15,000, and Roger and Kristina $40,000 each in damages.

Gooseybear wrote: TLTF had a PR department that was poor at best and they got rid of them a while back. Scientists typically aren't the best at communicating with the public and investor community. They need a professional CFO and Investor relations team to move forward.


<< Previous
Bullboard Posts
Next >>